DC Funds, LP

Est. AUM

$1.49B

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	TSCAN THERAPEUTICS INC	COM	$630.0M	630000	42.40%	SOLE
2	WEREWOLF THERAPEUTICS INC	COM	$490.5M	589102	33.01%	SOLE
3	BARINTHUS BIOTHERAPEUTICS PL	ADS	$365.4M	642204	24.59%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.